Experimental coronavirus retinopathy (ECOR): Retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection
Authors:
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 193 (1-2) , 28-37
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Immunobiology of SARSAnnual Review of Immunology, 2007
- IL-10 regulation of lupus in the NZM2410 murine modelLaboratory Investigation, 2006
- Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brainProceedings of the National Academy of Sciences, 2006
- Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signalingJournal of Clinical Investigation, 2006
- Coronavirus infection of the central nervous system: host–virus stand-offNature Reviews Microbiology, 2006
- Chemokines provide the sustained inflammatory bridge between innate and acquired immunityCytokine & Growth Factor Reviews, 2005
- CXC Chemokine Ligand 10 Controls Viral Infection in the Central Nervous System: Evidence for a Role in Innate Immune Response through Recruitment and Activation of Natural Killer CellsJournal of Virology, 2004
- Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal InfectionJournal of Virology, 2003
- Retinopathies Associated with Antiretinal AntibodiesClinical and Diagnostic Laboratory Immunology, 2001
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994